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Abstract: Uncertainty regarding transmission pathways and control measures makes prompt
presentation and diagnosis for Buruli ulcer critical. To examine presentation and diagnosis delays in
Victoria, Australia, we conducted a retrospective study of 703 cases notified between 2011 and 2017,
classified as residing in an endemic (Mornington Peninsula; Bellarine Peninsula; South-east Bayside
and Frankston) or non-endemic area. Overall median presentation delay was 30 days (IQR 14–60 days),
with no significant change over the study period (p = 0.11). There were significant differences in
median presentation delay between areas of residence (p = 0.02), but no significant change over
the study period within any area. Overall median diagnosis delay was 10 days (IQR 0–40 days),
with no significant change over the study period (p = 0.13). There were significant differences in
median diagnosis delay between areas (p < 0.001), but a significant decrease over time only on the
Mornington Peninsula (p < 0.001). On multivariable analysis, being aged <15 or >65 years; having
non-ulcerative disease; and residing in the Bellarine Peninsula or South-East Bayside (compared to
non-endemic areas) were significantly associated with shorter presentation delay. Residing in the
Bellarine or Mornington Peninsula and being notified later in the study period were significantly
associated with shorter diagnosis delay. To reduce presentation and diagnosis delays, awareness
of Buruli ulcer must be raised with the public and medical professionals, particularly those based
outside established endemic areas.
Keywords: Buruli ulcer; Australia; epidemiology; Mycobacterium ulcerans; skin ulcer; Tuberculosis
and other mycobacteria
1. Introduction
Buruli ulcer is a destructive bacterial infection of skin and soft tissue caused by the toxin-producing
environmental pathogen Mycobacterium ulcerans, which is most prevalent in sub-Saharan Africa [1].
Buruli ulcer is also an escalating public health issue in the temperate Australian state of Victoria,
with incidence increasing since 2012 to a record high of 340 cases in 2018 [2]. The majority of Victoria’s
6.4 million population reside in the metropolitan area of the state capital, Melbourne. Cases occur
in residents and visitors to low-lying coastal areas considered endemic for the disease (Figure 1),
many of which receive large numbers of visitors from non-endemic regions during summer. There is a
seasonal pattern to disease onset—most infections become clinically apparent in autumn and winter,
reflecting likely acquisition during summer or autumn based on an incubation period of up to nine
months (median 4.8 months) [3,4]. Since 2012, incidence has declined in the long-established Bellarine
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Peninsula endemic area, but has increased rapidly on the Mornington Peninsula, and to a lesser extent
in the South-East Bayside suburbs [3].
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Buruli ulcer may manifest as an ulcer, papule, subcutaneous nodule or raised plaque. If 
untreated, it can progress to significant ulceration, tissue loss and bone involvement, resulting in 
permanent disfigurement and long-term morbidity [1]. Less commonly, the disease may present as 
an oedematous lesion, often characterised by an intact dermis with cellulitis and low-grade fever. 
This form of the disease can be rapidly progressive and lead to extensive tissue loss. Oedematous 
lesions may be misdiagnosed as cellulitis, leading to delays in the diagnosis and treatment [6]. 
Combination oral antibiotic therapy (rifampicin with clarithromycin or a fluoroquinolone) for a 
minimum of eight weeks is the first-line treatment for uncomplicated Buruli ulcer in Victoria [7]. 
Successful antibiotic treatment is often followed by prolonged wound healing time; a recent study in 
Victoria described a median of 138 days (interquartile range (IQR) 91–175 days) [8].   
Given the current lack of effective interventions to reduce transmission, prompt diagnosis and 
treatment remain paramount. Delays in seeking medical care, confirming diagnosis, and 
commencing treatment can contribute significantly to morbidity through extended treatment and 
healing times, long-term disfigurement, and increased treatment costs [6,9,10]. Since a 2007 study 
focused on cases on the Bellarine Peninsula between 1998 and 2006 [11], there has been little research 
on factors influencing presentation and diagnosis delays in Victoria. Using routine surveillance data, 
this study aimed to characterise presentation and diagnosis delays for Buruli ulcer cases notified to 
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Uncertainties about the exact mode of transmission, environmental reservoirs and drivers of
emergence have hampered the design and implementation of effective interventions to reduce disease
transmission. However, basic preventative measures such as avoiding mosquito bites and skin
abrasions have been promoted by health authorities [5].
Buruli ulcer may manifest as an ulcer, papule, subcutaneous nodule or raised plaque. If untreated,
it can progress to significant ulceration, tissue loss and bone involvement, resulting in permanent
disfigurement and long-term morbidity [1]. Less commonly, the disease may present as an oedematous
lesion, often characterised by an intact dermis with cellulitis and low-grade fever. This form of the
disease can be rapidly progressive and lead to extensive tissue loss. Oedematous lesions may be
misdiagnosed as cellulitis, leading to delays in the diagnosis and treatment [6]. Combination oral
antibiotic therapy (rifampicin with clarithromycin or a fluoroquinolone) for a minimum of eight weeks
is the first-line treatment for uncomplicated Buruli ulcer in Victoria [7]. Successful antibiotic treatment
is often followed by prolonged wound healing time; a recent study in Victoria described a median of
138 days (interquartile range (IQR) 91–175 days) [8].
Given the current lack of effective interventions to reduce transmission, prompt diagnosis and
treatment remain paramount. Delays in seeking medical care, confirming diagnosis, and commencing
treatment can contribute significantly to morbidity through extended treatment and healing times,
long-term disfigurement, and increased treatment costs [6,9,10]. Since a 2007 study focused on cases on
the Bellarine Peninsula between 1998 and 2006 [11], there has been little research on factors influencing
presentation and diagnosis delays in Victoria. Using routine surveillance data, this study aimed
to characterise presentation and diagnosis delays for Buruli ulcer cases notified to the Victorian
Department of Health and Human Services (DHHS) between 2011 and 2017, and identify factors
influencing these delays.
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2. Materials and Methods
2.1. Study Population
Buruli ulcer is a notifiable condition in Victoria, with mandatory reporting by clinicians and
laboratories to DHHS. The initial study population included all laboratory-confirmed cases in Victorian
residents diagnosed in Victoria and notified to DHHS from 2011 to 2017. If case presentation or
diagnosis delay could not be ascertained due to missing data, they were excluded from the final
study population.
2.2. Data Sources
Since 2011, Buruli ulcer case surveillance data were collected by the Victorian DHHS from medical
practitioners using a standard surveillance form that includes demographic, clinical, treatment and risk
history information. Data relevant to presentation and diagnosis delays are the date of first health care
presentation, date of symptom onset, duration of symptoms before seeking care, and date on which
Buruli ulcer was first clinically suspected. Many cases were initially diagnosed by a primary care
doctor before referral to an infectious diseases specialist, meaning that the surveillance form may be
completed by more than one medical practitioner. DHHS staff endeavour to contact all cases without
a known link to a recognised endemic area by telephone for a detailed interview using a standard
questionnaire. Data collected on enhanced surveillance forms and questionnaires were recorded in an
electronic database.
2.3. Definitions
A confirmed case of Buruli ulcer required definitive laboratory evidence of infection, defined as
the detection and specific identification of Mycobacterium ulcerans by culture on a specimen of tissue or
a swab from a lesion (by the Mycobacterium Reference Laboratory at the Victorian Infectious Diseases
Reference Laboratory) or the detection of the IS2404 insertion sequence by polymerase chain reaction.
Residential location was defined as the geographic area where the case was living at the
time of notification. Geographic areas of residence were categorised into four areas (based on
local government area boundaries) considered endemic for Buruli ulcer in Victoria—Mornington
Peninsula, Bellarine Peninsula, South-east Bayside and Frankston Area. All other areas of Victoria
were categorised non-endemic.
Lesion severity was classified as per World Health Organization definitions [12]. Category I was
defined as a single lesion <5 cm diameter; Category II a single lesion 5–15 cm diameter; Category III a
single lesion >15 cm, multiple lesions, lesions at a critical site (e.g., the eye) or osteomyelitis.
Presentation delay was defined as days from symptom onset to first presentation to a medical
practitioner. Diagnosis delay was defined as days from presentation to a medical practitioner to first
clinical suspicion of Buruli ulcer.
2.4. Data Analysis
De-identified data were extracted into Microsoft Excel and imported into STATA 15.1
(College Station, TX, USA) for analyses.
Data were descriptively analysed to characterise the study population. Presentation and diagnosis
delays were described using median, IQR and range. The significance of change over time in median
presentation and diagnosis delays were assessed using Kruskal–Wallis tests.
Univariate Cox’s proportional hazards regression was used to identify significant associations
between each dependent variable (presentation delay, diagnosis delay) and independent variables
(age group, gender, year of notification, residential location at the time of notification, manifestation,
lesion location, WHO lesion category). As the time-dependent variables represent a positive outcome
(presentation or diagnosis), a hazard ratio of >1 indicates an association with shorter delay. Significance
was assessed by the likelihood ratio test, with all independent variables with a P-value of <0.25
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on univariate analysis considered for inclusion in a full multivariate model. A backward stepwise
regression procedure (p ≤ 0.05) was performed to refine and select the final variables for the main effects
model. Proportionality assumptions were tested using Schoenfeld and scaled Schoenfeld residuals.
The fit of the final model was evaluated using Cox–Snell residuals. Any presentation or diagnosis
delays recorded as zero days in the dataset were re-coded as 0.01 days for this analysis.
2.5. Ethics
Human research ethics approval was granted by the Australian National University Human
Research Ethics Committee on 17 July 2018 (2018/442).
3. Results
3.1. Characteristics of the Study Population
Between 2011 and 2017, 877 confirmed cases of Buruli ulcer were notified to DHHS, and 703
(80%) cases were included in the study. Excluded were 174 cases for which presentation or diagnosis
delay could not be ascertained from surveillance data. Significant differences were noted between the
included and excluded cases for the clinical variables of lesion location, manifestation and WHO lesion
category, likely because these data were collected primarily via surveillance forms which were not
consistently completed by clinicians. Residential location differed between the included and excluded
cases, reflecting more intensive public health follow-up of cases notified outside recognised endemic
areas. The characteristics of the total, excluded and included cases are described in Table 1.
Table 1. Characteristics of Buruli ulcer cases (total, included and excluded for analysis) notified to the
Victorian Department of Health and Human Services from 2011 to 2017.
Total Notifications Included for Analysis Excluded for Analysis P-Value
no. % no. % no. %
Sex 0.15
Female 391 44.6 305 43.4 86 49.4
Male 486 55.4 398 56.6 88 50.6
Age group 0.95
<15 years 96 11.0 77 11.0 19 10.9
15–65 years 495 56.4 395 56.2 100 57.5
>65 years 286 32.6 231 32.9 55 31.6
Residential location <0.001
Bellarine Peninsula 184 21.0 113 16.1 71 40.8
Mornington Peninsula 245 27.9 198 28.2 47 27.0
South-East Bayside 63 7.2 52 7.4 11 6.3
Frankston Area 75 8.6 58 8.3 17 9.8
Non-endemic 310 35.4 282 40.1 28 16.1
Lesion location <0.001
Upper Limb 199 22.7 167 23.8 32 18.4
Lower Limb 515 58.7 425 60.5 90 51.7
Other * 104 11.9 91 12.9 13 7.5
Unknown 59 6.7 20 2.8 39 22.4
Manifestation <0.001
Ulcer 644 73.4 549 78.1 95 54.6
Non-ulcer † 154 17.6 138 19.6 16 9.2
Unknown 79 9.0 16 2.3 63 36.2
WHO lesion category <0.001
I 619 70.6 539 76.7 80 46.0
II 110 12.5 91 12.9 29 10.9
III 60 6.8 55 7.8 5 2.9
Unknown 88 10.0 18 2.6 70 40.2
* includes lesions on areas of the body other than limbs, and lesions in multiple locations (including limbs). † includes
all non-ulcerative Buruli ulcer manifestations.
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Incidence increased over the study period in all areas except the Bellarine Peninsula,
where incidence decreased from 35 cases in 2011 to 11 cases in 2017. The greatest increase in
incidence was observed for cases on the Mornington Peninsula, from four cases in 2011 to 88 cases
in 2017. Cases residing in non-endemic areas also increased significantly over the study period,
from 17 cases in 2011 to 109 cases in 2017. The number and proportionate distribution of cases over the
study period by area of residence is summarized in Figure 2.
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3.2. Presentation and Diagnosis Delays
3.2.1. Presentation Delay
Overall median presentation delay was 30 days (IQR 14–60 days), with no significant change
over the study period (p = 0.11). Significant differences in median presentation delay between
areas of residence were observed over the study period (p = 0.02), with shortest delay in South-east
Bayside (19 days, IQR 7–35.5 days), followed by the Bellarine Peninsula (21 days, IQR 14–42 days),
Mornington Peninsula (29.5 days, IQR 14–56 days), and Frankston and non-endemic areas (both 30 days,
IQR 14–60 days). No significant change in median presentation delay was observed within any of the
areas of residence over the study period (Figure 3).
3.2.2. Diagnosis Delay
Overall median diagnosis delay was 10 days (IQR 0–40 days), with no significant change observed
over the study period (p = 0.13). Significant differences in median diagnosis delay between areas of
residence were observed (p < 0.001). Median diagnosis delay was shortest on the Bellarine Peninsula
(0 days, IQR 0–7 days) and the Mornington Peninsula (0 days, IQR 0–19 days), followed by Frankston
(16 days, IQR 3–45 days), South-east Bayside (20.5 days, IQR 1–61 days) and non-endemic areas
(29 days, IQR 7–56 days). Significant decrease in median diagnosis delay over the study period
was observed only for the Mornington Peninsula (p < 0.001), however the median remained at zero
days for all years of the study period on the Bellarine Peninsula. Non-significant decreases were
observed in South-East Bayside and Frankston. No decrease was observed for the non-endemic areas.
Median diagnosis delay over the study period by area of residence is illustrated in Figure 3.
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3.3. Factors Influencing Presentation and Diagnostic Delays
3.3.1. Presentation Delay
Table 2 provides a summary of associations between independent variables and presentation delay
on univariate and multivariate Cox regression analysis. In the final multivariate model, being aged
<15 years or >65 years, having non-ulcerative disease, and residing in the Bellarine Peninsula or
South-East Bayside compared to a non-endemic area remained significantly associated with shorter
presentation delay.
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Table 2. Associations between independent variables and presentation delay on univariate and
multivariate Cox’s regression analysis.
Observations
Median Delay
(days)
Univariate Multivariate
Crude HR 95% CI P-Value Adjusted HR 95% CI P-Value
Sex
Female 305 28 1.06 0.91–1.23 0.47
Male 398 30 Reference
Age group
<15 years 77 21 1.31 1.02–1.67 0.03 1.35 1.04–1.73 0.02
15–65 years 395 30 Reference Reference
>65 years 231 23 1.29 1.09–1.52 0.002 1.31 1.10–1.55 0.002
Residential location
Bellarine Peninsula 113 21 1.20 0.97–1.50 0.10 1.26 1.01–1.58 0.04
Mornington Peninsula 198 29.5 1.07 0.89–1.28 0.48 1.06 0.88–1.28 0.53
South-East Bayside 52 19 1.40 1.04–1.88 0.03 1.44 1.06–1.95 0.02
Frankston area 58 30 0.88 0.66–1.17 0.38 0.87 0.65–1.17 0.36
Other (non-endemic) 282 30 Reference Reference
Lesion location
Upper limb 167 30 Reference
Lower limb 425 30 1.04 0.87–1.24 0.69
Other * 91 21 1.16 0.89–1.49 0.27
Manifestation
Ulcer 549 30 Reference Reference
Non-ulcer † 138 21 1.28 1.06–1.54 0.01 1.27 1.05–1.53 0.02
Year of notification
Increasing from 2011 703 - 0.97 0.93–1.00 0.06
WHO lesion category
I 539 30 1.07 0.85–1.33 0.57
II 91 28 Reference
III 55 28 1.30 0.93–1.81 0.13
* includes lesions on areas of the body other than limbs, and lesions in multiple locations (including limbs). † includes
all non-ulcerative Buruli ulcer manifestations. HR = hazard rate CI = confidence interval. Bold type indicates
significance for inclusion in the full and main effects models.
3.3.2. Diagnosis Delay
Table 3 provides a summary of associations between independent variables and diagnosis delay
on univariate and multivariate Cox regression analysis. In the final multivariate model, residing in the
Bellarine Peninsula or Mornington Peninsula compared to a non-endemic area and being notified later
in the study period remained significantly associated with shorter diagnosis delay.
Table 3. Associations between independent variables and diagnosis delay on univariate and multivariate
Cox’s regression analysis.
Observations
Median Delay
(days)
Univariate Multivariate
Crude HR 95% CI P-Value Adjusted HR 95% CI P-Value
Sex
Female 305 14 0.89 0.77–1.04 0.14
Male 398 7 Reference
Age group
<15 years 77 19 0.84 0.66–1.08 0.17
15–65 years 395 13 Reference
>65 years 231 7 1.08 0.92–1.28 0.33
Residential location
Bellarine Peninsula 113 0 2.63 2.09–3.30 <0.001 3.18 2.47–4.09 <0.001
Mornington Peninsula 198 0 1.97 1.63–2.37 <0.001 1.94 1.60–2.35 <0.001
South-East Bayside 52 20.5 1.04 0.77–1.39 0.82 1.07 0.79–1.44 0.67
Frankston area 58 16 1.17 0.88–1.55 0.28 1.21 0.91–1.61 0.19
Other (non-endemic) 282 29 Reference Reference
Lesion location
Upper limb 167 12 Reference
Lower limb 425 13 1.02 0.85–1.22 0.823
Other * 91 6 1.14 0.88–1.47 0.32
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Table 3. Cont.
Observations
Median Delay
(days)
Univariate Multivariate
Crude HR 95% CI P-Value Adjusted HR 95% CI P-Value
Manifestation
Ulcer 549 10 Reference
Non-ulcer † 138 13.5 0.95 0.79–1.15 0.60
Year of notification
Increasing from 2011 703 - 1.03 0.99–1.06 0.19 1.09 1.04–1.13 <0.001
WHO lesion category
I 539 9 1.26 1.01–1.58 0.04
II 91 19 Reference
III 55 31 0.87 0.62–1.22 0.41
* includes lesions on areas of the body other than limbs, and lesions in multiple locations (including limbs). † includes
all non-ulcerative Buruli ulcer manifestations. HR = hazard rate CI = confidence interval. Bold type indicates
significance for inclusion in the full and main effects models.
4. Discussion
This study found that despite a significant difference in median presentation delay between areas
of residence, presentation delay had not significantly decreased in Victoria as a whole, or in any specific
area during the period 2011–2017. There was a significant association between shorter presentation
delays and residence in South-East Bayside or Bellarine Peninsula. This is consistent with a recent
study by Loftus et al. (using a similar surveillance dataset covering 2011–2016), which identified
shortest presentation delays for cases with likely exposure to the disease on the Bellarine Peninsula
compared to the rest of Victoria, however the difference was not considered significant [3]. Significant
association between cases aged <15 years or >65 years and shorter presentation delays is also consistent
with previous findings [3]. Significant association between shorter presentation delays and having
non-ulcerative disease has been previously identified in a study in Benin [13].
There was no significant decrease in median diagnosis delay in Victoria as a whole, however
a significant decrease was observed on the Mornington Peninsula even as case numbers increased
year on year, reaching a zero-day median in 2016. There was a significant association between shorter
diagnosis delays and residence in Bellarine or Mornington Peninsula, and with diagnosis later in the
study period. These findings are consistent with previous studies in Victoria, which identified shortest
diagnosis delays in established endemic areas [3,11,14]. A recent study using a similar surveillance
dataset found that most cases in non-endemic areas had a likely exposure to one or more of the endemic
areas during their plausible acquisition period [3].
The zero-day median diagnosis delay on the Bellarine Peninsula throughout the study period is
likely reflective of its longer history as an endemic area and higher clinical index of suspicion among
local medical practitioners. Likewise, the significant decrease on the Mornington Peninsula is likely
related to growing medical practitioner and resident familiarity with the disease over the study period
as case numbers increased locally and the disease received additional attention from public health
authorities, the medical community and the media. The results of the multivariate analysis support this
hypothesis, with residence in the two areas that have previously or are currently experiencing intense
endemic transmission being associated with significantly shorter diagnosis delay. DHHS has made
significant efforts to raise awareness of the disease as it has emerged in these areas, including advisory
notices from the state’s Chief Health Officer and an online continuing professional development
module for primary care doctors [5,15].
The association between shorter presentation delays and cases being aged <15 years or >65 years
may be due to an increased caution about health issues in children and older people. A previous
Victorian study found that children and older people are at greater risk of severe Buruli ulcer disease [2].
The association between shorter presentation delays and non-ulcerative disease may be because these
symptoms (i.e., oedema, cellulitis and plaques) are less likely to be dismissed as insect bites, are often
rapidly progressive and can involve systemic symptoms like fever.
Trop. Med. Infect. Dis. 2019, 4, 100 9 of 10
This study utilized a large, robust surveillance dataset and included 80% of cases notified in
Victoria over the study period. Limitations included the retrospective nature of surveillance data, and
exclusion of cases due to missing data, and the fact that the majority of cases resided in endemic areas,
which may have biased the data. We were also unable to include other factors that may impact on
presentation and diagnosis delays such as medical co-morbidities, occupation, social connectivity,
socioeconomic status, educational level or geographic distance to health care facilities as these are not
collected as part of routine surveillance. Place of residence was recorded only at the time of notification
and may be different to when the disease was acquired or diagnosed, due to the potentially extended
incubation period and delays in presentation and diagnosis.
On a global scale, delays in presentation and diagnosis for Buruli ulcer in Victoria are relatively
short—a study of 82 Nigerian patients in Benin identified a median delay from symptom onset to
diagnosis of 29 weeks (IQR 12–234) [16]. Lengthy delays have also been reported in Cameroon
(median 12 weeks, IQR 3–30, n = 105) and Nigeria (median 12 weeks, IQR 6–50, n = 145) [17,18].
It is important to recognise the differing drivers for delays in each context—whilst geographical and
economic inaccessibility to health care and an initial preference for traditional healing methods have
been identified in Africa, [16,19] these are highly unlikely to be important factors in Victoria.
To further reduce delays in diagnosis, public health authorities must continue to find ways to
engage with and effectively raise clinician awareness of Buruli ulcer, particularly those based outside
the recognised endemic areas. Clinicians may be unfamiliar with or have a low level of clinical suspicion
if patients acquired Buruli ulcer many months earlier while visiting an endemic area. This contention
is supported by the relatively lengthy diagnosis delays observed for cases residing in non-endemic
areas compared to those in recognised endemic areas, and the lack of an observable decrease in median
diagnosis delay over the study period.
The absence of a decrease in presentation delay over the study period suggests that a review
of public health communications and community engagement (including the importance of early
presentation, early diagnosis and preventative measures) may be warranted. In a study of 85 patients in
the Bellarine Peninsula, seeing media related to Buruli ulcer was a significant factor in seeking diagnosis
for nearly one quarter of cases [11]. A review of communications and community engagement could
gauge the effectiveness of current strategies for raising awareness among local communities and
visitors to endemic areas and identify areas for improvement.
As Buruli ulcer incidence continues to increase in Victoria, effective interventions to reduce
transmission are limited due to continuing uncertainty regarding the modes of transmission.
Effective risk communication and awareness remain critical to reducing the disease burden.
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